MARKET

PACB

PACB

PacBio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.280
-0.290
-8.12%
After Hours: 3.280 0 0.00% 16:41 03/27 EDT
OPEN
3.370
PREV CLOSE
3.570
HIGH
3.500
LOW
3.170
VOLUME
1.07M
TURNOVER
--
52 WEEK HIGH
7.50
52 WEEK LOW
2.200
MARKET CAP
502.28M
P/E (TTM)
-5.9377
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PACB and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PACB stock price target is 6.00 with a high estimate of 7.00 and a low estimate of 5.00.

EPS

PACB News

More
  • Jury Declines To Validate Pacific Biosciences' Patents In U.S. Patent Trial Against Oxford Nanopore
  • Benzinga · 03/18 20:26
  • Statement on Jury Verdict in Delaware Trial Against Oxford Nanopore Technologies
  • GlobeNewswire · 03/18 18:52
  • Pacific Biosciences down 19% after patent ruling
  • Seeking Alpha - Article · 03/18 18:18
  • The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
  • Benzinga · 03/17 15:38

Industry

Advanced Medical Equipment & Technology
-2.20%
Healthcare Equipment & Supplies
-1.86%

Hot Stocks

Symbol
Price
%Change

About PACB

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.
More

Webull offers kinds of Pacific Biosciences of California stock information, including NASDAQ:PACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PACB stock news, and many more online research tools to help you make informed decisions.